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Abstract
Most complex disease-associated genetic variants are located in
non-coding regions and are therefore thought to be regulatory in
nature. Association mapping of differential allelic expression (AE) is
a powerful method to identify SNPs with direct cis-regulatory
impact (cis-rSNPs). We used AE mapping to identify cis-rSNPs regu-
lating gene expression in 55 and 63 HapMap lymphoblastoid cell
lines from a Caucasian and an African population, respectively, 70
fibroblast cell lines, and 188 purified monocyte samples and found
40–60% of these cis-rSNPs to be shared across cell types. We
uncover a new class of cis-rSNPs, which disrupt footprint-derived
de novo motifs that are predominantly bound by repressive factors
and are implicated in disease susceptibility through overlaps with
GWAS SNPs. Finally, we provide the proof-of-principle for a new
approach for genome-wide functional validation of transcription
factor–SNP interactions. By perturbing NFjB action in lympho-
blasts, we identified 489 cis-regulated transcripts with altered AE
after NFjB perturbation. Altogether, we perform a comprehensive
analysis of cis-variation in four cell populations and provide new
tools for the identification of functional variants associated to
complex diseases.
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Introduction
The vast majority of Genome-Wide Association Studies (GWAS)
variants for complex diseases lie in non-coding DNA (~90%) and
are specifically enriched in areas of open chromatin in cell types that
are relevant to the disease of interest (Manolio et al, 2009; Maurano
et al, 2012). These non-coding variants are thought to act primarily
through altering regulation of gene expression in cis. Characteriza-
tion and prediction of the cell-type specificity of cis-regulatory varia-
tion are therefore important in identifying causal disease-relevant
cis-rSNPs (Pastinen, 2010). To date, most studies investigating cis-
regulatory variation have utilized expression quantitative trait loci
(eQTL) mapping, where variants are tested for their association with
gene expression (Schadt et al, 2003). While eQTL studies have
proven to be a powerful tool in investigating the genetics of gene
expression in a broad sense, the investigation of cis-regulatory
mechanisms requires an approach that isolates the role of cis-rSNPs
to transcription. The cis-acting components of expression variation
can be identified through the mapping of differences in allelic
expression (AE), which is the measure of relative expression
between two allelic transcripts (Ge et al, 2009). The parallel geno-
typing of genomic DNA and RNA (cDNA) on high-density genotyp-
ing chips allows interrogation of AE variation across transcribed
loci, including both exons and introns. Since both alleles are
impacted by the same trans-acting and environmental effects, AE
mapping reduces the complexity of gene expression to its cis compo-
nents. A recent study showed that this approach greatly improved
the sensitivity of detecting cis-rSNPs compared to standard eQTL
mapping and demonstrated that an eightfold decrease in sample size
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is sufficient to achieve the same statistical power as in standard
eQTL mapping (Almlof et al, 2012). Studies of AE mapping in
lymphoblastoid cell lines (LCLs) have revealed that approximately
30% of all loci have significant AE imbalance, with cis-rSNPs
explaining more than 50% of the population variance in AE (Ge
et al, 2009). The effect of cis-rSNPs on other disease-relevant cell
types depends on the proportion of regulatory elements that are
shared between cell types, compared to those that are specific to a
single cell type or restricted to a small subset of cell types. Earlier
eQTL studies have suggested that over 50% of cis-rSNPs are shared
between any two tissues, for example, LCLs and fibroblasts (Emilsson
et al, 2008; Kraft, 2008; Dimas et al, 2009; Ding et al, 2010).
Large-scale functional mapping projects, such as ENCODE, have
generated massive collections of high-resolution functional genom-
ics data. However, much of this information has yet to be integrated
with studies on population expression variation (The ENCODE
Project Consortium, 2012). Hundreds of new transcription factor
(TF) recognition motifs that exhibit cell-selective occupancy were
discovered using DNase I footprinting (Neph et al, 2012), providing
the opportunity to study new DNA elements in conjunction with
population variation. Importantly, these projects have reported a
large fraction of open and functional chromatin sites to be cell-type
specific. This is in contrast with previous eQTLs reports, which
showed considerable sharing in functional regulatory variation
across tissues (Emilsson et al, 2008; Kraft, 2008; Dimas et al, 2009;
Ding et al, 2010; The ENCODE Project Consortium, 2012; Thurman
et al, 2012).
Despite progress in mapping functional elements, defining causal
cis-rSNPs among correlated sites in high linkage disequilibrium (LD)
remains a challenge. Traditional tools such as reporter gene assays
typically isolate the putative regions from their functional chromatin
context (Cirulli & Goldstein, 2007). New approaches for the global
functional assessment of the molecular bases of mapped associa-
tions are needed.
This study utilizes the allelic expression approach to investigate
the genetic determinants of differential allelic expression of protein-
coding and non-coding genes across four cell populations. We
examine TF binding site disruption by mapped cis-rSNPs and inves-
tigate their regulatory role on gene expression across tissues.
Finally, we propose a novel platform to globally examine the role of
key regulators by combining allelic expression read-outs with
targeted approaches to perturb TFs in living cells.
Results
Quantitative allelic expression measurements and mapping in 4
cell populations
Genome-wide quantitative AE measurements were carried out on
Human1M-Duo BeadChips (Ge et al, 2009) for four populations
covering 3 distinct cell types. As in our previous work, we used both
intronic and exonic SNPs passing the signal intensity threshold, with
75% of the SNPs used for AE mapping located intronically in non-
processed transcripts. We restricted our analysis to differences in
normalized allele ratios in RNA (cDNA) at heterozygous sites aver-
aged across fully annotated primary transcripts (Grundberg et al,
2011), in order to detect allelic differences impacting full transcripts,
rather than changes in splicing or 30 usage (Ge et al, 2009) (see
Methods). In addition to 55 HapMap lymphoblastoid cell lines
(LCLs) from a Caucasian population (CEU), we included 63 LCLs
from an African population (YRI), 70 fibroblast cell lines from a
Caucasian population (FBs) (Wagner et al, 2014), and 188 purified
monocyte samples (MNCs) from unrelated healthy donors residing
in the UK (Almlof et al, 2012). This selection of cell types enabled
us to capture a wide range of potential cis-variants and aided in the
fine mapping of common variants between populations.
The application of the BeadChip genotyping process, which
includes amplification, allows for the detection of rare transcripts.
In order to focus on genes with biologically relevant expression
levels, we restricted our analysis to expressed loci independently
determined using RNA-seq expression data, with up to eight
samples per cell type (see Methods). Using this method, we identi-
fied 11,723, 9,982, and 11,487 non-overlapping expressed tran-
scripts in LCLs, fibroblasts, and monocytes, respectively. We next
applied a filter for the statistical significance of genetic effects on
allelic expression in order to limit the discovery of false-positive
associations, requiring that loci be mapped below the threshold of
1% FDR (see Methods). This led to the detection of 49, 36, and 81%
of allelically regulated transcripts in LCLs, fibroblasts, and mono-
cytes, respectively. Examples of proximal and distal allelic expres-
sion associations in individual transcripts are depicted in Fig 1. In
order to include the optimal number of associated SNPs in our
analysis, we assessed simulated candidate loci with known “causal”
sites (Supplementary Methods). Through the simulation analysis,
we observed that the percentage of missing causal SNPs is below
5% when the top 10 ranked SNPs by P-value are included per locus,
and thus, we focused our subsequent analyses using this cutoff
(Supplementary Fig S1). A summary of mapped associations and
number of tested SNPs are displayed in Table 1 and Supplementary
Table S1, respectively.
All classes of transcripts annotated in GENCODE V15 were
included in our analysis. This allowed us to map cis-regulatory vari-
ants for 266 lincRNAs, 642 processed transcripts, 308 antisense tran-
scripts, and 15 sense-intronic transcripts (Supplementary Table S2).
Shared cis-regulatory variation is high between cell types
and populations
In order to assess the biological relevance of cis-regulatory variation
between the four cell population panels, we defined cell-type-
specific and shared associations. We applied a stringent approach to
assess exactly shared top associations across tissues requiring not
only significant association in both tissues, but also converging
association pattern. To account for cases of detecting true cis-
regulatory associations at weak significance levels, which could
result in underestimating the number of shared associations, we
used a method that is conceptually similar to that used by Nica et al
(2011). For each locus, all primary associations in one population
were compared to the first percentile of mapped SNPs in another cell
population (see Methods). We observed 10–23% of SNP-transcript
associations in each tissue (same population) as shared in the two
others and that a majority is shared between at least two tissues
(Table 1 and Supplementary Table S3). Monocytes showed the
highest (61%) proportion of cell-selective associations. We also
identified 38–48% of loci shared between different ethnicity (CEU
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Figure 1. Examples of allelic expression mapping in individual transcripts.
Regression tests were carried out using phased AE data: y-axis shows the mean D het ratio across all individuals heterozygous for top SNP across population or the D het ratio
for individual examples. NA19099 and NA18507 in panel (A) and NA 18871 and NA19172 in panel (B) are heterozygous for top SNP, and profiles reflect differential AE at
population level. NA19172 and NA19128 in panel (A) and NA19128 and NA18853 in panel (B) are homozygous for top SNP and show weak differential AE with no significant
bias toward one haplotype.
A Example of cis-rSNP located close to the TSS of its associated transcript. Differential AE of RAB31 is associated to rs1893126 genotype.
B Example of cis-rSNP located far away from its associated transcript. The strongest association for CACNA1E is rs12077014 and is located > 53 kb from its TSS.
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versus YRI LCLs) of the same cell type (Supplementary Table S3).
We noted that this tissue sharing is conservative as compared to
methods recently used to estimate tissue sharing in eQTL studies
allowing for uncertainty in mapping accuracy (Grundberg et al,
2012). Estimates of pairwise tissue sharing based on p1 values are
similar to eQTL studies and range from 39% between YRI LCLs
and fibroblasts to over 60% for monocyte lead associations and
the three other sample panels (Supplementary Table S4) (see Meth-
ods). We explored the relevance of mapped shared associations in
full datasets using IPA (Ingenuity Systems, www.ingenuity.com).
Networks of genes associated to cis-rSNPs shared across all three
studied cellular lineages are involved in basic cellular functions
(Supplementary Fig S2). In contrast, associations shared by the
two LCL panels are enriched in cell-to-cell signaling and immune
response networks, and associations shared between lymphoblasts
and monocytes are enriched in networks related to immunological
disease and immune response. Finally, we hypothesized that the
variation in the number of mapped loci, which are tissue indepen-
dent or cell-type selective, could be due to differences in the
number of analyzed samples, leading to discovery of weaker
effects less likely to be shared across tissues in larger samples.
Down sampling to equally powered datasets (see Supplementary
Methods) shows the ratio of cell type-dependent versus all associa-
tions is quite stable across comparisons, suggesting that the level
of sharing we observed is mainly influenced by (i) tissue-depen-
dent differences, where cultured cells of Caucasian origin (CEU
and FB) show lowest level of tissue differentiation and (ii) popula-
tion genetic variation (YRI versus all others) where sequence diver-
gence predominates (Supplementary Fig S3).
To improve the mapping resolution, we next applied meta-
analyses across populations (see Methods). By breaking up blocks
of SNPs in high LD, this approach significantly reduced the total
number of associated SNPs per loci by ~2.1-fold (chi-squared test,
P < 2 × 1032, Supplementary Fig S4) (Hess & Iyer, 2007). Intersect-
ing our data with the RegulomeDB (RegDB) database (Boyle et al,
2012) yielded a significant enrichment of mapped SNPs overlapping
functional elements (1.1-fold, chi-squared test, P = 0.02). A signifi-
cant increase in the proportion of GWAS hits (1.9-fold, chi-squared
test, P = 2 × 1016) was also observed, particularly in autoimmune
diseases (1.5-fold, chi-squared test, P = 1.4 × 1032). These findings
may be partially attributed to the use of two immune cell types
(lymphoblasts and monocytes) among the three cell lineages stud-
ied. The spatial distribution of the mapped cis-rSNPs follows an
expected trend (Nica et al, 2011): high density of sites in 50UTRs,
gene bodies, and 30UTRs, which rapidly decreases as a function of
the distance from the gene in flanking regions. The associations
shared between cell populations display a striking enrichment at the
TSS of the associated transcript. In parallel, we observe a depletion
of cell-type-specific associated variants at the TSS, with a simulta-
neous increase in more distal associations (Supplementary Fig S5).
Only 0.4% of all rSNPs associations localized further than 200 kb
away from the associated transcript. The density of long-range asso-
ciations may be slightly underestimated for the monocyte sample
due to reliance on statistical rather than family-based approach in
phase assignment and potential of confounding errors in long-range
haplotypes. We observe rate of long-range effects of 0.2% in mono-
cytes versus 1.1% in the three other cell types. Overall, these data
support the validity of our approach to map high-quality cis-
regulatory variants in different cell population.
We further observed the same cis-rSNP to be associated to AE of
multiple transcripts (up to 10) in the same cell population for 35%
of all mapped transcripts (n = 3825). Moreover, we detect the oppo-
site allelic direction of regulatory effect for transcripts linked to the
same cis-rSNPs in 33% of these cases. Two examples of these
complex loci are depicted in Supplementary Fig S6. We previously
reported this type of effect for a single disease locus (Verlaan et al,
2009) and showed an impact of genetic variants on higher order
chromatin function. Supplementary investigation would be needed
to establish if this could be a common phenomenon across human
cell types.
Table 1. Number of mapped loci per gene type and cell population.
Cell Types
Lymphoblastoid Cell Lines-CEU Lymphoblastoid Cell Lines-YRI Fibroblasts Monocytes
Number of samples 55 63 70 188
Total number of associations 3343 3982 3983 8175
Number of associations per gene type
Protein-coding 2938 3486 3526 7367
lincRNA 74 109 89 156
Processed transcripts 200 241 234 437
Antisense transcripts 108 118 115 162
Sense-intronic transcripts 6 6 3 11
Others 17 22 16 42
Cell-selective associationsa 1293 (39%) 1997 (50%) 1610 (40%) 4978 (61%)
Shared across all tissuesb 613 (23%) – 668 (19%) 769 (9.5%)
Shared across all tissues and populationsc 407 (15%) 371 (12%) 435 (13%) 485 (6%)
aSNP–transcript associations mapped in one cell population.
bSNP–transcript associations mapped in CEU LCLs, fibroblasts, and monocytes (same population).
cSNP–transcript associations mapped in CEU LCLs, YRI LCLs, fibroblasts, and monocytes.
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Cis-rSNPs are linked with disease variants
To investigate the role of mapped regulatory variants and disease,
cis-rSNPs for each cell-type specificity class were intersected with
hits from the NHGRI Catalog of Published GWAS at genome-wide
significance (P < 5 × 108). In total, we identified 540 loci with at
least one cis-rSNP in nearly absolute LD (r2 ≥ 0.9) with a disease
hit (Table 2; Supplementary Table S5). These cis-rSNPs showed
a high degree of functionality, with 42.2% of them falling into
categories 1–5 from RegDB, which is significantly higher than
for all cis-rSNPs in our study (34.8%) (chi-squared test,
P = 3.8E × 1023). Transcripts for non-coding RNAs, including
lincRNA, antisense, processed and sense-intronic RNAs, represent
7.8% (n = 42) of the disease-associated loci. One interesting exam-
ple is located in the genomic region 3q12.3, where rs771767, a SNP
linked by GWAS to multiple sclerosis, localizes to an intergenic
region > 168 Kb from the closest protein-coding gene (Fig 2A–B)
(International Multiple Sclerosis Genetics C, Wellcome Trust Case
Control C, 2011). This variant is located in a region of open chro-
matin (ENCODE data) and, in our data, is the top-ranked cis-rSNP
(P = 1.96 × 106) for the lincRNA RP11-221J22.1. This association
is specific to monocytes, a cellular lineage with a role in instigating
neuroinflammation in multiple sclerosis disease models (Hendriks
et al, 2005). Globally, we found a correlation between the catego-
ries of traits of the GWAS hits and the cell-type specificity of the
cis-rSNPs with which they are in LD (Fig 2C). SNPs associated to
hematological traits are significantly enriched (1.9-fold, chi-squared
test, P < 0.01) in cis-rSNPs mapped in monocytes. We also
observed a significant enrichment (chi-squared test, P < 0.05) of
variants associated with auto-immune diseases among the cis-
rSNPs mapped in the immune-related cell types, the lymphoblasts
(1.6-fold), and the monocytes (1.4-fold), as has been earlier
observed in eQTL studies (Fairfax et al, 2012). Finally, we identi-
fied shared genetic effects between autoimmune diseases as previ-
ously described (Cotsapas et al, 2011). One key example is located
in 9q34.3: rs3812560 (RegDG score = 1f), which is linked to four
different diseases, and is associated to differential allelic expression
of at least five genes (Supplementary Fig S7), suggesting that
rs3812560 may act as a master regulator, involved in multiple
physiological contexts and diseases. Molecular investigation of the
role of rs3812560 and other master regulators may be beneficial in
the elucidation of the shared mechanisms involved in the develop-
ment of autoimmune diseases.
Motif disruption at cis-rSNPs revealed new regulatory function
One mechanism by which cis-rSNPs may act and mediate disease
risk is through the disruption of transcription factor binding sites.
Databases of TF binding matrices, such as TRANSFAC (http://
www.biobase-international.com), can be used to detect these
events. However, they contain only a minority of the human tran-
scription factors with predicted high-quality sequence-specific DNA
binding domains (Vaquerizas et al, 2009). Recently, Neph et al
(2012) performed unbiased de novo motif discovery within the foot-
prints left by regulatory factor binding to genomic DNA and protect-
ing the underlying sequence from cleavage by DNase I in 41 cell
types. This approach allowed them to discover 683 unique de novo
motifs (numbered 1–683), 289 of which showed no match in previ-
ous motif databases. This new genome-wide dataset of transcription
factor binding, in conjunction with the major motif database
TRANSFAC which contains 721 motifs, provides an opportunity to
interrogate both known and unknown DNA–protein interactions
that may be affected by cis-rSNPs.
To investigate the relationship between cis-rSNPs and TF bind-
ing, we used the FIMO motif scanning software (see Methods) to
calculate the number of disrupted binding sites per motif at
cis-rSNPs based on cell-type specificity (Supplementary Table S6).
As expected, sites for general transcription factors such as SP1,
AP1/2, and CTCF are frequently disrupted in all cell types (Supple-
mentary Table S7). However, we also observed cell-type-specific
activity at TRANSFAC and footprint-derived motifs (Fig 3) (chi-
squared test, P < 0.05): For example, binding motifs for NFjB and
IRF factors and the de novo motif “616” are frequently disrupted in
LCLs in agreement with previous studies (Ernst et al, 2011; Neph
et al, 2012). Motifs for FOXO3A and PU.1 factors are more specific
to fibroblasts and monocytes (Ito et al, 2009; Wang et al, 2014).
We next explored the regulatory role of factors binding TRANS-
FAC and footprint-derived motifs by combining allele-specific matrix
affinity scores at cis-variants with the AE data of the associated tran-
script. Motifs for transcriptional activators are expected to exhibit a
higher matrix score for the same haplotype as the overexpressed
allele, while inhibitors should more frequently recognize the haplo-
type for the under-expressed allele. Using genotypes at cis-variants
from the four population panels, we systematically compared the
matrix score between both alleles and across all sites where a given
motif was found. We identified 63 motifs (11%) with significant
matrix score allelic bias (P binomial test < 0.01) (Table 3 and
Supplementary Table S8). Among these, 41 (65%) were associated
with an activatory activity: We observed significantly more cases
where the “higher matrix score” was on the same haplotype as the
more expressed allele. The vast majority of these potential activator-
binding sites overlapped a known motif from TRANSFAC (76%).
The most significant of these motifs bind well-known transcriptional
activators: NFjB, CEBP (CCAAT/enhancer-binding family), and
PU1, a lymphoid-specific enhancer (Kueh et al, 2013). Overall, nine
“de novo” motifs present potential enhancer activity (P binomial
test < 0.01).
We identified 22 motifs with significantly more cases where the
“higher matrix score” was on the same haplotype as the expected
under-expressed allele, suggesting a repressor activity. Several of
the top 10 most significant motifs are bound by factors with
published inhibitory activity, such as NRSF (a.k.a. REST) (Chong
Table 2. Number of loci with a cis-rSNP in high LD with SNP from the
GWAS catalog.
Number of loci with
cis-rSNP in high LDa with
a GWAS hit (LD ≥ 0.9)
Number of
locus–disease
associationsb
Cell-selectiveb 360 418
Shared by at least
2 cell types
182 230
Shared by all
cell types
20 25
Total 540 648
ar2 > 0.9
bAs a same cis-regulatory variant can be associated to multiple diseases, the
total number of locus–disease associations are also reported.
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et al, 1995; Schoenherr & Anderson, 1995) with an extensively
documented repressor activity, HFH4, a FOX factor (Hoggatt
et al, 2000; Myatt & Lam, 2007), or PAX5 (Fazio et al, 2008).
Unexpectedly, we also identified many “de novo” motifs among the
most significant hits: 79% of the “de novo” motifs are bound by
factors with repressive function (Fig 4A). To exclude bias due to
the way in which matrices were produced with the “DNase I foot-
printing” method, we examined footprint-generated motifs which
had not been called as “de novo” due to redundancy with other
datasets (Neph et al, 2012). We observed a majority of “activators”
(62%), a proportion more similar to the motifs from the TRANSFAC
database (90%), suggesting no bias in the footprint-derived motif
generation (Fig 4A). To further validate these findings, we assessed
chromatin state at cis-rSNP sites where motifs are disrupted (see
Methods) (Degner et al, 2012). We used in-house, high-depth
H3K4me3 ChIP-seq data generated in LCLs. When looking at all
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Figure 2. Cis-rSNPs are linked with disease variants.
A The most significant cis-regulatory variant of RP11-221J22.1 mapped by regression analysis in the monocyte population, rs771767 (P = 1.96 × 106), is also a GWAS
hit linked to multiple sclerosis.
B Screenshot of the rs771767 genomic region from the UCSC genome browser.
C Proportion of cis-rSNPs in high LD with GWAS hits in each disease category. Both LCLs and monocytes showed significant enrichment in autoimmune diseases
(P < 0.05). Monocyte-specific cis-rSNPs are enriched in hematological traits (P < 0.01, *P < 0.05, **P < 0.01).
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cis-rSNPs (P < 1.10E9), we observed significant enrichment
(~1.2-fold, t-test, P = 5.4 × 107) on the same haplotype of the
expected overexpressed allele, confirming global enhancer activity
for most of the cis-variants. In contrast, when we restricted the
analysis to cis-rSNPs leading to the disruption of a “repressor” site,
we observed the opposite trend (~1.2-fold, t-test, P = 3.2 × 104,
Fig 4B). Overall, these data suggest that the disruption of repressor
activity is an important source of heritable cis-regulatory variation
and that repressor–DNA interactions are under-represented among
annotated transcription factor binding sites (TFBS).
Next, we asked whether the cis-rSNPs associated with repressor
activity were enriched in GWAS hits. We first identified 129 loci
where cis-variants are in high LD (r2 ≥ 0.9) with a disease hit and
alter matrix scores for motifs associated to enhancer or repressor
activity as described above. Among them, 66 cis-variants sit on a
predicted repressor binding site. For example, rs2303369, which has
been linked to age at onset of menopause, is in high LD (r2 = 0.9)
with rs780100, a cis-regulatory variant which disrupts a repressor
binding site for the de novo motif “607”, and is associated to differ-
ential AE of NRBP1, a gene with a growth-promoting role, in the
monocyte population (P = 2.7 × 1027) (Fig 4C and D) (Ruiz et al,
2012; Stolk et al, 2012). In order to validate the binding of a repres-
sor factor, we examined allelic ChIP-seq signals for H3K4me3 at
rs780100 across all individuals that are heterozygous for this vari-
ant. We observed a significantly higher signal (~twofold, chi-
squared test, P < 0.001 for all individuals except for MNC491 with
P < 0.05) for active chromatin on the same haplotype as the less
expressed allele, reinforcing our hypothesis of a repressor binding
NRBP1 promoter region (Fig 4E) (Light et al, 2014). It is also
interesting to note that the risk allele is associated to the repression
of this gene.
Taken together, the fine-mapped cis-rSNPs point toward frequent
involvement of both known and currently uncharacterized tran-
scription factors in the variation of gene expression in cell popula-
tions and in the pathogenesis of complex diseases. The global
Figure 3. Heat map of differential motif disruption by cis-rSNPs
according to the cell type.
Heat map representing disruption frequency of motifs for TF binding sites
(TRANSFAC, left panel; footprint-derived de novo, right panel) in LCLs, fibroblasts,
and monocytes. Only motifs significantly enriched or depleted in at least one
tissue are represented (P-value chi-squared < 0.05). Low disruption: white; high
disruption: dark red. Numbers on the right panel correspond to the unique de
novo motifs numbered 1–683 as defined by Neph et al (see main text).
Table 3. Table of TF biding sites with the most significant global
activator or repressor activity.
Activity Motif P-valuea Bias=#over/#underb
Activators V_PU1_Q4 1.33E-06 1.72
V_PU1_Q6 2.53E-06 2.61
V_CEBP_C 1.11E-05 3.11
V_ELK1_01 2.04E-04 2.02
V_NFKAPPAB_01 2.66E-04 2.30
V_GADP_01 3.42E-04 1.78
V_P53_01 5.35E-04 2.28
V_GABP_B 8.57E-04 1.61
572 8.78E-04 1.44
413 9.08E-04 1.60
154 9.66E-04 1.74
V_NKX3A_01 1.07E-03 3.33
Repressors 421 1.46E-05 0.55
481 6.43E-04 0.42
275 9.12E-04 0.63
V_HFH4_01 1.05E-03 0.45
V_NUR77_Q5 1.40E-03 0.36
V_PAX5_01 2.22E-03 0.33
373 2.46E-03 0.36
V_NFY_Q6_01 2.67E-03 0.43
217 2.78E-03 0.65
V_NRSF_01 2.83E-03 0.58
aBased on global higher matrix score deviation toward the haplotype of the
expected over or under-expressed allele.
bTotal number of motifs with higher matrix score on the expected over or
under-expressed allele.
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Figure 4. Footprint-based de novo motifs are enriched for repressor activity and linked to diseases.
A Proportion of disrupted motifs by cis-rSNPs for TF binding sites with globally significant activator or repressor activity (P binomial test < 0.01). Motifs are split into
three categories: (i) footprint-based de novo motif with no match in any other major motif database; (ii) footprint-based de novo motif with a match in other major
motif database: TRANSFAC, JASPAR, and UniPROBE databases (Neph et al, 2012); (iii) TRANSFAC motifs. Whereas TRANSFAC and previously known footprint-based
motifs are mostly bound by activators, true de novo motifs showed enrichment for repressor binding sites.
B ChIP-seq read depth is correlated to genotype of cis-rSNPs. Average normalized read depth according to genotype and across all LCL samples (n = 7) is depicted for
H3K4me3 at all cis-rSNPs (P < 1.1 × 109) or at top cis-rSNPs associated to a change in a recognition motif for a repressor motif. For all mapped cis-rSNPs, ChIP-
seq coverage is significantly higher (P = 5.4 × 107) for homozygotes for the expected overexpressed allele (blue line) as compared to homozygotes for the opposite
allele (red line). We observed the opposite trend for repressor sites (P = 3.2 × 104).
C–E Example of a repressor site in high LD with a GWAS hit. (C) Variant rs2303369 is associated to age of onset of menopause. It is in high LD with rs780100, located in
active chromatin and associated to differential AE of NRBP1. (D) AE linear regression graph. Regression test was carried out using phased AE data: y-axis shows the
D het ratio, left dots correspond to heterozygotes carrying the B-allele in phased chromosome 2 (“0” on the x-axis), middle dots to homozygotes (“1” on the x-axis),
and right dots to heterozygotes carrying the A-allele in phased chromosome 2 (“2” on the x-axis). (E) A recognition site for the de novo motif “607” is found at the
location of rs780100 on the same haplotype as the under-expressed allele; no motif is recognized on the other haplotype. Allelic ChIP-seq for H3K4me3 at this site
showed significant bias toward the expected, under-expressed allele across all heterozygous individuals (*P < 0.05, ***P < 0.001) (first 6 samples = LCLs, last two
samples are from fibroblast and monocyte (MNC491) cell population, respectively).
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enrichments alone, however, are insufficient to confirm the role of
specific TFs at defined loci.
Genome-wide validation of NFjB allelic regulation in LCLs
For confirmation of TF–cis-rSNP interactions in a functional context,
we developed a method that perturbs TF followed by monitoring
genome-wide allelic expression measurements in living cells. As a
model for this novel approach, we chose the factor NFjB. Activation
of NFjB is known to regulate the expression of genes that are
involved in the pathogenesis of inflammatory pathologies (Kempe
et al, 2005; Sehnert et al, 2013) and SNPs associated to diseases are
enriched in NFjB binding regions (Karczewski et al, 2013). Three
motifs for NFjB binding (“V_NFΚB_C”, “V_NFΚB_Q6_01”, and
“V_NFKAPPAB_01”) are associated with significant global enhancer
activity (P binomial test < 0.01) in this dataset (Supplementary
Table S8). We observed that cis-rSNPs from 126 loci disrupted one
of these NFjB binding sites are preferentially located in NFjB ChIP-
seq peaks (ENCODE) (6.5-fold, chi-squared test, P = 2.6 × 1023),
when compared to other mapped loci in LCLs suggesting true regu-
lation by this TF. Among these cis-rSNPs, 12 are in high LD with
GWAS hits for 12 diseases and linked to differential allelic expres-
sion of 15 genes. Overall, both the literature and our own data
support NFjB as an interesting biological model to test this novel
approach. Briefly, we performed TNF-a induction coupled to inhibi-
tion of NFjB in LCLs followed by AE analysis on Illumina Human-
Omni5-Quad BeadChips (see Methods). Samples used included two
HapMap trios: one from the CEU (GM12891, GM12892, and
GM12878) and one from the YRI (GM19239, GM19238, and
GM19240) population. Validation of NF-jB knockdown was done
using RT–PCR of known gene targets for NFjB (Supplementary Fig
S8) (Mori & Prager, 1996; Catz & Johnson, 2001; Kang et al, 2007;
Son et al, 2008). We looked for transcripts with AE differences in
cells induced by TNF-a compared to cells induced by TNF-a in
combination with inhibition of NFjB. We observed perturbation of
AE of many known NFjB targets, such as CXCL17, SERPINE2, and
IL-1A/IL-1B (Hiscott et al, 1993; Mori & Prager, 1996; Suzuki et al,
2006; Takegawa et al, 2008; Supplementary Table S9). Within the
transcripts included for mapping in the CEU and YRI population, we
identified 489 transcripts that are allelically regulated by NFjB,
according to AE pertubation in at least two individuals heterozygous
for the top cis-rSNP (see Methods). Using ENCODE NFjB ChIP-seq
experiments, we observed significantly (~1.1-fold, chi-squared test,
P = 4 × 1017) higher NFjB signals at cis-rSNP locations from
perturbed than non-perturbed transcripts, validating the global cis-
regulation of perturbed genes by NFjB (Fig 5A). We then investi-
gated whether the loci responding to NFjB perturbation and
mapped in at least 1 cell population were associated to complex
diseases according to an overlap between cis-rSNPs and GWAS hits
(LD ≥ 0.9). We identified 26 transcripts that are perturbed by NFjB
and had a regulatory variant linked to a complex disease, including
immune-related and/or autoimmune diseases such as systemic
lupus erythematosus (SLE), multiple sclerosis and Kawasaki disease
(Supplementary Table S9). We focused on the BLK region, which is
linked to SLE susceptibility, and for which we had previously fine-
mapped the promoter region (Ge et al, 2009). Using significantly
more individuals (118 CEU and YRI LCLs versus 53 CEU LCLs), we
identified rs998683 (RegDB = 1f) as the most strongly associated
SNP to differential AE of BLK (ENST00000259089.4) in the LCL
population. This variant is located in the first intron of BLK gene
and may act as an enhancer. We observed a change in AE of BLK
after NFjB perturbation (Fig 5B–C) and an overlap of rs998683 with
an NFjB ChIP-seq peak, which strongly supports the role of NFjB
in the regulation of BLK expression. Another example of converging
functional data supporting the role of NFjB in the circulating plas-
minogen activator inhibitor-1 (PAI-1) concentration through the
allelic regulation of SERPINE1 is depicted in Supplementary Fig S9.
Interestingly, we observed among the mapped and perturbed genes
a significant enrichment of lincRNAs and processed transcripts
(~twofold, chi-squared test, P = 4.4 × 1020).
These results demonstrate that whole-genome perturbation of TF
activity associated with allele-specific assessment and mapping can
be successfully used to identify pathways and functional roles of
regulatory variation associated to disease.
Discussion
In this study, we mapped cis-regulatory variants in three cell
types, examined their global impact on TF binding sites and demon-
strated a new approach to validate the role of key regulators by
combining allelic expression mapping data with targeted approaches
to perturb TFs in living cells. The large fraction of discovered cis-
regulatory variants in three cell types is in line with data from recent
eQTL studies using RNA sequencing of blood cells or lymphoblasts
(Lappalainen et al 2013, Battle et al 2014). We were able to achieve
an equivalent number of associations using lower sample sizes due
to the greater power of allelic expression measurements (Almlof
et al, 2012). When shared associations are observed, the feasibility
to fine-map cis-regulatory variants is improved by parallel applica-
tion of meta-analyses across cell types as shown by their greater
power to predict functionality. Finally, our results detect that up to
40–60% of cis-rSNPs that were originally mapped in each cell type
show strong evidence of tissue independence, demonstrating a large
pool of regulatory elements where sequence context predominates
as determinate of variance. This reflects the strong sequence depen-
dence of cis- regulation (Wilson et al, 2008).
Global investigation of the disruption of TF binding sites by cis-
rSNPs can contribute to identifying important cell-type-specific
regulatory factors and to distinguish functional variants associated
to disease. Our analysis revealed that TFs with an inhibitory activ-
ity are likely to be more prevalent than previously thought. This
inhibitory activity is more common for TF binding to de novo foot-
print-derived motifs than to known motifs from TRANSFAC. The
fact that a TF can act as a repressor or an activator, depending on
the chromatin or cellular context, appears to be a limitation for
comprehensive mapping of repressor activity. Here, we focused on
factors with a major global repressive activity. The knowledge of
GWAS-
associated variants implicated in repressor binding could be of
practical importance in, for example, confirming the desired modu-
lation of gene targets or their regulators in GWAS-based drug
repositioning (Sanseau et al, 2012).
The intersection of cis-rSNPs with variants from the GWAS catalog
reveals a large number of shared hits, with a remarkable enrichment
of mapped variants from relevant cell types with disease types.
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Immune-related diseases are overrepresented in LCLs and monocyte-
specific-associated SNPs, which are cell types with a well-known role
in auto-immune diseases (Kwan et al, 2008; Zhang et al, 2008; Mont-
gomery et al, 2010; Pickrell et al, 2010; Fairfax et al, 2012), reiterat-
ing the importance of using cellular lineages that match the disease
biology. We observe that phenotypically important SNPs are enriched
for complex transcriptional variation in populations where multiple
independent transcripts are affected. This intriguing observation in
some loci may have a biological basis, but in practice, it suggests that
comprehensive characterization of genetically variable transcription
in the vicinity of trait SNPs is essential to assign functional mecha-
nisms to disease haplotypes (Verlaan et al, 2009).
A recent method proposed to investigate endogenous regulatory
elements by selectively altering their chromatin state using program-
mable reagents (Mendenhall et al, 2013). Although promising, this
method does not allow for genome-wide assessment of TF regula-
tory activity and their associated transcripts. We demonstrated a
new approach for in vivo exploration of genome-wide functional
activity of a transcription factor, focusing on NFjB given its key role
in immune regulation. We validated allele-specific differences in TF
binding in the human genome and successfully identified transcripts
that are allelically regulated by NFjB in LCLs and whose regulatory
activity is associated to complex diseases. We noticed an enrich-
ment of lincRNAs and processed transcripts in genes regulated by
A B
C
Figure 5. Direct assessment of allele-specific NFjB binding highlights target genes and its implication in diseases.
A ENCODE NFjB ChIP-seq signal at cis-rSNPs. We observe higher signal for transcripts that are allelically perturbed by NFjB. Lines represent normalized NFjB ChIP-
seq read count for NFjB perturbed (blue) and unperturbed (red) transcripts. P-values were calculated with the chi-squared test using the read counts at the SNP
position.
B Allelic perturbation of BLK after treatment with helenalin/TNF-a, TNF-a, DMSO, or after no treatment. The value 1 on the y-axis represents equal expression of the
two alleles of BLK. A complete or partial loss of allelic imbalance is observed after specific inhibition of NFjB (red) in cells heterozygous for rs998683 (GM19238,
GM19239, and GM12891). No difference in allelic expression between treatments is observed for homozygous individuals (GM12892 and GM12878).
C Screenshot of the rs998683 (cis-rSNP of BLK) region from the UCSC genome browser. An overlap between rs998683 and the NFjB ChIP-seq peak is seen in a LCL
sample.
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NFjB. We hypothesize that lincRNAs are more easily perturbed due
to their lower stability versus protein-coding genes or that there are
fewer post-transcriptional mechanisms that buffer the effect of cis-
rSNPs in lincRNAs. This result also supports a potential role of non-
coding RNA in modulation of inflammatory processes. Our novel
approach to perturb NFjB and monitor the consequences of the
perturbation on a genome-wide scale can be generically extended to
other transcription factors or combinations of them in different cell
types. Moreover, this approach may be used to test specific TF activ-
ity on isolated cells from patients and thereby identify allele-specific
differences with controls.
Future analyses using allele-specific expression data for mapping
cis-variants and for in vivo genome-wide assessment of TF activity
in populations of diverse cell types hold tremendous promise for the
large-scale identification of the specific causal variants that affect
gene expression detected by genome-wide association studies for an
assortment of complex diseases.
Materials and Methods
Cell preparation and cDNA synthesis
All LCLs were obtained from Coriell (Camden, NJ, USA) and cultured
as previously described (Ge et al, 2009). Fibroblast cell lines were
obtained from Coriell and the McGill Cellbank (Montreal, QC,
Canada) and grown in medium containing a-MEM (Sigma-Aldrich,
Oakville, ON, Canada) supplemented with 2 mmol/l L-glutamine,
100 U/ml penicillin, 100 mg/ml streptomycin, and 10% fetal bovine
serum (Sigma-Aldrich) at 37°C with 5% CO2. At 70–80% confluence,
the cells were harvested and stored at 70°C until RNA and DNA
extraction. RNA was extracted from cell lysates, and we applied a
cDNA synthesis protocol as previously described (Ge et al, 2009).
Circulating monocytes were collected from healthy adult blood
donors of European origin (n = 188) recruited from the United King-
dom National Blood Service Centre in Cambridge, UK, as part of the
Cardiogenics Transcriptomic Study (Garnier et al, 2013). The
Cambridgeshire 1 Research Ethics Committee approved the donor
recruitment. CD14+ magnetic microbeads (autoMACS Pro, Miltenyi
Biotec, Bergisch Gladbach, Germany) were used to isolate mono-
cytes from whole blood. RNA was extracted from cell pellets, and
cDNA was prepared as previously described (Almlof et al, 2012).
RNA-seq samples preparation
Total RNA from LCLs (x3), fibroblasts (x4), and primary monocytes
(x8) were extracted from cell lysates using the miRNeasy Mini Kit
(Qiagen, Mississauga, Canada) (including a DNase I treatment step)
with the quality assessed by Agilent 2100 BioAnalyzer (Agilent Tech-
nologies, Palo Alto, CA, USA). Libraries for RNA sequencing were
prepared according to the Illumina TruSeq protocol. The quality of
each library was assessed by Agilent 2100 BioAnalyzer. Samples were
indexed and sequenced on Illumina Genome Analyzer II (paired-end
2 × 76 bp) or on Illumina HiSeq 2000 (paired-end 2 × 100 bp). High-
quality RNA-seq reads were aligned to the human reference genome
build hg19 using Tophat v1.4.1 (Trapnell et al, 2012). Annotated tran-
scripts (Gencode V15) with median FPKM score > 0.01 across
samples were considered as expressed (Trapnell et al, 2010).
AE mapping and normalization of allele ratios in
Illumina Beadchips
AE mapping was performed as previously described (Ge et al, 2009)
except for the signal intensity normalization at heterozygous sites,
which followed a slightly modified approach (Grundberg et al,
2011). Briefly, approximately 200 ng of genomic DNA and a 50–
300 ng double-stranded cDNA sample was used for the parallel
genotyping and AE analysis on the Illumina Infinium Human1M or
Human1M-Duo SNP bead microarray according to the manufac-
turer’s instructions. Raw data were processed in the genotyping
module (Ver. 3.3.7) of BeadStudio software (3.1.3.0), filtered and
normalized. For transcript-based AE regression tests, associations
were carried out using average intensity signal for SNPs (minimum
three per transcript) across any annotation from GENCODE version
15. We used 1000 Genomes project data as a reference set (release
1000G Phase I v3, updated 26 Aug 2012) for the imputation of geno-
types from our panel of HapMap individuals. Untyped markers were
inferred using algorithms implemented in IMPUTE2 (Howie et al,
2009). R2 was used as an imputation quality control metric, which
estimates the squared correlation between imputed and true geno-
types. We systematically removed all poorly imputed markers with
r2 < 0.8. For each gene, only the most highly expressed isoform
with minimum FPKM value of 0.01 was retained. In regression tests,
we decided to exclude intensity signal from genomic regions over-
lapped by more than one gene to avoid conflicting data. We called
“partial-length transcripts” in cases where only part of the AE data
were used due to these low confidence regions. For “full-length”
transcripts, no region was excluded. The AE associations were
tested in phased chromosomes with D het ratio data correlated with
local (500-kb flanking sequence) genotypes, the marginal (at 0.01
permutation significance level) associations observed in either
population from non-overlapping transcripts. The number of tested
SNPs per cell population can be found in Supplementary Table S1.
Overall, 4939556, 7659025, 4947257 and 4933245 SNPs with
MAF ≥ 0.05 were tested in CEU LCLs, YRI LCLs, fibroblasts, and
monocyte population, respectively, using 12411 full- and 3901
partial-length transcripts. To be conservative, loci were included
only if the P-value of the most significant association was less than
the P-value at 1% FDR, which was 3.282 × 106, 1.263 × 106,
4.238 × 106 and 3.276 × 105 for the CEU LCLs, YRI LCLs, fibro-
blasts, and monocytes, respectively.
Shared associations and Fisher combined test
For each locus, all primary associations from each population were
compared to the first percentile of mapped SNPs in others cell popula-
tion. A P-value cutoff of 1.1 × 104 was used in the secondary popu-
lation. At this threshold, > 95% of mapped associations showed the
same direction of effect between two populations. When at least one
regulatory variant was found in common, we considered this locus as
sharing regulatory activity between these populations. A Fisher’s
combined approach was then used to improve mapping resolution
and generate new associations for shared loci across populations.
To allow comparison of our approach to recent works reporting
higher level of sharing, we used same approach for comparing
P-values between datasets. Specifically, we took lead association in
one tissue (based on our definition by FDR) and fetch exactly the
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data for same SNP-transcript pair in the other tissues. We used as
input these P-value lists in the R package “qvalue” and run the
default setting in the two datasets separately. The output p0 in the
summary file is used to calculate p1 values (1-p0), which represents
the proportion of shared hits among the tested. This approach is
more liberal and allows for uncertainties of mapping accuracy in
differently powered datasets; consequently, pairwise sharing esti-
mated based on this approach is substantially higher (40–60%).
To evaluate the potential functionality of these new associations,
we intersected our data with the RegulomeDB (RegDB) database
(Boyle et al, 2012). Categories 1–5 were used to indicate active regu-
latory regions (a lower score indicating stronger evidence of func-
tionality), whereas categories 6 and 7 are attributed to SNP with low
potential of functionality.
ChIP-seq samples preparation
Cells were cross-linked with 1% formaldehyde at room temperature
for 10 min. After quenching with glycine for 5 min (125 mM glycine
per ml of media), the cells were washed twice with ice-cold PBS.
Cells were collected after each wash by centrifugation at 2,000 g for
5 min. Cell pellets were flash-frozen and stored at 80°C. Frozen
pellets were thawed, and cells were lysed in Farnham lysis buffer
(5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40 and protease inhibi-
tors) for 10 min on ice. After centrifugation and a wash with 1 ml of
RIPA buffer containing 50 mM Tris–HCl pH 8, 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibi-
tors, lysates were diluted with 500 ll of RIPA buffer to proceed to the
sonication step. Cells were sonicated in non-stick tubes under condi-
tions optimized to yield soluble chromatin fragments in a size range
of 100–250 base pairs. Chromatin from 40 million cells was sonicated
for 10 min using a Branson 250 sonicator at 20% power amplitude
(pulses: 10 s on and 30 s off). Lysate was clear by centrifuging at
12,000 g for 10 min at 4°C to eliminate cellular debris. Chromatin
was then flash-frozen and stored at 80°C or used immediately for
the next step. Before each immunoprecipitation, chromatin was pre-
cleared with 50 ll of pre-washed ProteinA-magnetic beads (Invitro-
gen; 100-02D) to avoid non-specific binding. Immunoprecipitation
was carried out for 12 hours by rotation at 4°C in 500 ll of chroma-
tin/RIPA buffer supplemented with protease inhibitor cocktails
(Roche; 04 693 159 001) and PMSF. We used 10–30 million cells and
2–5 lg of the following antibodies for each assay: H3K4me1 (abcam;
ab8895) and H3K4me3 (Diagenode; #pAb-003-050). After overnight
incubation, samples were rotated with 100 ll of pre-washed Protein-
A-magnetic beads at 4°C for 1 h. The beads were then collected by
brief centrifugation at 2,000 g following by the use of a magnetic
rack. Beads were washed five times with 1 ml of LiCl wash buffer
(100 mM Tris pH 7.5, 500 mM LiCl, 1% NP-40, 1% sodium deoxy-
cholate) by resuspending the beads and keeping them on ice for
10 min. Bound chromatin was then eluted from the beads by incuba-
tion with 200 ll of elution buffer (50 mM Tris–HCl, pH 8.0, 10 mM
EDTA, 1.0% SDS) at 65°C for 1 h with vortexes performed every
15 min. This was followed by a centrifugation at 14,000 g at room
temperature for 3 min. The eluted chromatin and the “input” sample
were then incubated at 65°C overnight after adding 0.2 M of NaCl to
reverse cross-links. Samples were then treated with RNase A at 37°C
for 30 min, followed by digestion with proteinase K at 55°C for 1 h.
Immunoprecipitated DNA was then purified using QIAquick PCR
Purification Kit (QIAGEN; 28104) and eluted to a final quantity of
30 ll. Enrichments of interesting regions were validated using real-
time PCR experiments. Primers were designed to genomic sites
known to bind H3K4me1 and H3K4me3 enriched or not enriched
(negative control) regions. Library preparation for ChIP-seq assays
was carry out using Paired-End DNA Sample Prep Kit V1 (Illumina;
PE-102-1001) and sequenced using the Illumina Genome Analyzer II
(2 × 76 bp) or HiSeq Sequencing System (2 × 100 bp). The panel we
used consisted of 7 HapMap samples: 3 CEU LCLs (GM12891,
GM12892, and GM12878) and 4 YRI LCLs (GM19238, GM19239,
GM19240, and GM18507); 2 fibroblast cell lines from Coriell:
GM02456 and GM2555; 2 purified monocyte samples: MNC491 and
MNC492. Reads were trimmed for quality (phred33 ≥ 30) and length
(n ≥ 32) using Trimmomatic v. 0.22 (Bolger et al, 2014). The filtered
reads were aligned to the hg19 reference genome using BWA v. 0.61.
Peaks were calls using MACS v. 1.4.2 (Feng et al, 2012).
Motif over-representation and allelic positional bias
Matrices for TRANSFAC (version 2009.4) and de novo footprint-
derived motifs (Neph et al, 2012) were used in association with the
FIMO motif scanning software, version 4.9.0, using a P < 1 × 104
threshold, to find all motif instances  15 nucleotides from a mapped
cis-rSNP sitting on a DHS footprint region (Grant et al, 2011). All
motifs displaying no change in matrix affinity score, according to cis-
rSNP genotypes, were discarded. To account for multiple testing, we
used a Bonferroni correction (0.05/1380 = 3.62e-05). Among the de
novo motifs, 58% matched matrices from other databases (TRANS-
FAC, JASPAR or UniPROBE). These motifs were not considered as de
novo for the analyses. After normalization to a mean value of 0 and
variance 1, a heat map with 1 row per motif instance was generated
using matrix2png (Pavlidis & Noble, 2003), version 1.2.1. The full
dataset is accessible in Supplementary Table S6.
GWAS intersection
The GWAS catalog was obtained from http://www.genome.gov/
admin/gwascatalog.txt on June 26, 2012. We grouped SNPs into
classes of similar diseases or traits according to the classification
used by Maurano et al (2012).
Perturbation of NFjB
LCLs from HapMap trios from the CEU (GM12891, GM12892, and
GM12878) and YRI (GM19239, GM19238, and GM19240) LCL popula-
tions were used. Cells were plated in 6-well plates with 500,000 cells/
ml in 2 ml one day prior to the experiment. Cells were either
directly treated with TNF-a (3 ng/ul) for NFjB activation or primar-
ily transfected for one hour with helenalin (5 lM) (EMD Chemicals,
USA) in order to inhibit the activation of NFjB (p65) (Lyss et al,
1998). Helenalin is a sesquiterpene lactone that acts as a specific
NFjB DNA binding inhibitor by irreversibly alkylating free sulfhydr-
yls of the cysteine residues on the p65 subunit. Following this inhi-
bition, cells were stimulated with TNF-a (3 ng/ll) at time points
consisting of 4, 6, 8, 12, 24, and 48 h in order to select for the ideal
stop point. Validation of the perturbation of NFjB and induction by
TNF-a was done by RT–PCR for genes targeted by NFjB including
IL-6, IL-8, IL-1a, and Bcl-2. The most optimal time point to stop the
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experiment was deemed 8 hours post-transfection. Total RNA and
DNA were extracted for dscDNA synthesis. Differential AE was
assessed on Illumina HumanOmni5-Quad BeadChips for each experi-
mental condition: (1) inhibition with helenalin followed 1 h later by
activation by TNF-a (H-TNF-a); (2) activation by TNF-a (TNF-a);
(3) DMSO; and (4) no treatment. We selected NFjB perturbed genes
using the following criteria: differential allelic expression must be
higher in (2) than in (1) and with more than 1.2-fold change between
H-TNF-a and TNF-a in at least two individuals. We required that this
variation was measured in at least three independent heterozygous
SNPs in both conditions.
RT–PCR
Total RNA was annealed to 500 ng of random primers. First-strand
cDNA synthesis was performed using SuperScriptII reverse trans-
criptase (Invitrogen Corporation, Carlsbad, CA, USA) according to
the manufacturer’s recommendations and as described above. The
cycling conditions on the Rotor-GeneTM 6000 real-time rotary
analyzer were 4 min at 95°C, 40 cycles ×20 s at 95°C, 30 s at 58°C
and 30 s at 72°C, followed by the dissociation protocol at 72°C.
Results were analyzed using the comparative CT method. The CT
mean and standard deviation of each technical replicate were calcu-
lated, and the mean CT values were then normalized to the 18S
mean CT value. Primers were designed using the Primer3 v. 0.4.0
software (http://frodo.wi.mit.edu/), and all primer sequences used
can be found in Supplementary Table S10.
Data access
Primary Data:
cDNA and gDNA raw data for YRI LCLs can be accessed through the
GEO accession number GSE52442.
RNA-seq data for primary monocytes and YRI LCLs can be accessed
through the GEO accession number GSE53837.
ChIP-seq data for primary monocytes can be accessed through the
GEO accession number GSE53837.
cDNA and gDNA raw data after NFjB perturbation (treatment and
controls) for the two LCLs trio can be accessed through the GEO
accession number GSE61254.
Referenced Data:
cDNA and gDNA raw data for monocytes and fibroblasts can be
accessed through accession number EGAS00000000119 at EGA and
the GEO accession number GSE52442, respectively.
RNA-seq data for fibroblasts can be accessed through the GEO
accession number GSE53837.
ChIP-seq for fibroblasts and LCLs can be accessed through the GEO
accession number GSE53837.
Supplementary information for this article is available online:
http://msb.embopress.org
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